このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Baxter International マネジメント
マネジメント 基準チェック /24
Baxter International'sの CEO はJoe Almeidaで、 Jan2016年に任命され、 の在任期間は 8.42年です。 の年間総報酬は$ 13.79Mで、 9.4%給与と90.6%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.11%を直接所有しており、その価値は$ 18.73M 。経営陣と取締役会の平均在任期間はそれぞれ2年と4.3年です。
主要情報
Joe Almeida
最高経営責任者
US$13.8m
報酬総額
CEO給与比率 | 9.4% |
CEO在任期間 | 8.7yrs |
CEOの所有権 | 0.1% |
経営陣の平均在職期間 | 1.9yrs |
取締役会の平均在任期間 | 4.6yrs |
経営陣の近況
Recent updates
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?
Sep 05Baxter- Reiterating Our Buy Rating After A Promising Q2
Aug 07Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29
Aug 07Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
Jul 23Baxter: Why Investors Should Take Advantage Of The Low Valuation
Jul 16Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues
Jul 12Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 30Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
May 14Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
May 08Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 20Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden
Jan 28Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital
Jan 12Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares
Dec 28Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Dec 12Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)
Nov 27Is Baxter International (NYSE:BAX) A Risky Investment?
Oct 27Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
Oct 12There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital
Sep 21Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Aug 23Dividend Challengers Review: Baxter International
Aug 14Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Jul 25Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet
Jul 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture
Jun 07Baxter International's (NYSE:BAX) Dividend Will Be $0.29
May 19Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 05Baxter International Inc.'s (NYSE:BAX) Intrinsic Value Is Potentially 26% Above Its Share Price
Apr 24Is Baxter International (NYSE:BAX) Using Too Much Debt?
Apr 03CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$157m |
Mar 31 2024 | n/a | n/a | -US$38m |
Dec 31 2023 | US$14m | US$1m | -US$76m |
Sep 30 2023 | n/a | n/a | US$225m |
Jun 30 2023 | n/a | n/a | -US$3b |
Mar 31 2023 | n/a | n/a | -US$3b |
Dec 31 2022 | US$14m | US$1m | -US$3b |
Sep 30 2022 | n/a | n/a | -US$3b |
Jun 30 2022 | n/a | n/a | US$876m |
Mar 31 2022 | n/a | n/a | US$992m |
Dec 31 2021 | US$16m | US$1m | US$1b |
Sep 30 2021 | n/a | n/a | US$1b |
Jun 30 2021 | n/a | n/a | US$1b |
Mar 31 2021 | n/a | n/a | US$1b |
Dec 31 2020 | US$16m | US$1m | US$1b |
Sep 30 2020 | n/a | n/a | US$911m |
Jun 30 2020 | n/a | n/a | US$924m |
Mar 31 2020 | n/a | n/a | US$991m |
Dec 31 2019 | US$14m | US$1m | US$1b |
Sep 30 2019 | n/a | n/a | US$1b |
Jun 30 2019 | n/a | n/a | US$1b |
Mar 31 2019 | n/a | n/a | US$2b |
Dec 31 2018 | US$16m | US$1m | US$2b |
Sep 30 2018 | n/a | n/a | US$1b |
Jun 30 2018 | n/a | n/a | US$795m |
Mar 31 2018 | n/a | n/a | US$840m |
Dec 31 2017 | US$15m | US$1m | US$609m |
報酬と市場: Joeの 総報酬 ($USD 13.79M ) は、 US市場 ($USD 13.55M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Joeの報酬は増加しましたが、会社は利益を上げていません。
CEO(最高経営責任者
Joe Almeida (62 yo)
8.7yrs
在職期間
US$13,786,671
報酬
Mr. Jose E. Almeida, also known as Joe, has been the Chairman of the Board and Chief Executive Officer of Baxter International Inc. since January 1, 2016 and serves as its President since January 01, 2016....
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman of the Board | 8.7yrs | US$13.79m | 0.11% $ 21.9m | |
Executive VP | less than a year | US$5.37m | 0% $ 0 | |
Executive VP & Group President of Medical Products and Therapies | 1.5yrs | US$4.86m | 0.031% $ 6.1m | |
Executive VP & Group President of Pharmaceuticals | 2.2yrs | US$3.87m | 0.0024% $ 461.6k | |
Executive VP & Group President of Kidney Care | 1.3yrs | US$9.64m | 0.0046% $ 893.9k | |
Senior VP and Chief Medical & Scientific Officer | 1.7yrs | データなし | データなし | |
Senior VP & Chief Information Officer | less than a year | データなし | データなし | |
Vice President of Investor Relations | no data | データなし | データなし | |
Executive VP & General Counsel | 2.4yrs | US$5.66m | 0.0018% $ 354.0k | |
Senior Vice President | no data | データなし | データなし | |
Executive VP & Chief Human Resources Officer | 7.3yrs | US$4.14m | 0.037% $ 7.2m | |
Executive VP & Chief Supply Chain Officer | 4.7yrs | データなし | 0.0036% $ 704.2k |
1.9yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: BAXの経営陣は 経験豊富 とはみなされません ( 1.7年の平均在職年数)。これは新しいチームを示唆しています。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Chairman of the Board | 8.7yrs | US$13.79m | 0.11% $ 21.9m | |
Independent Director | 1.1yrs | US$197.82k | 0.0018% $ 348.2k | |
Chairman Emeritus | 8.7yrs | US$17.88m | データなし | |
Independent Director | 2.3yrs | US$349.64k | 0.0026% $ 508.6k | |
Independent Director | 7.6yrs | US$373.98k | 0.0055% $ 1.1m | |
Independent Director | 5.6yrs | US$364.98k | 0.0042% $ 819.6k | |
Independent Director | 2.8yrs | US$363.00k | 0.0028% $ 547.7k | |
Independent Director | 7.7yrs | US$367.31k | 0.0044% $ 864.6k | |
Lead Independent Director | 2.3yrs | US$382.31k | 0.0026% $ 508.6k | |
Independent Director | 3.6yrs | US$357.00k | 0.0032% $ 624.0k | |
Independent Director | 1.3yrs | US$226.35k | 0.0019% $ 377.5k | |
Independent Director | 5.6yrs | US$352.98k | データなし |
4.6yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: BAXの 取締役会 は 経験豊富 であると考えられます ( 4.3年の平均在任期間)。